70177635
liked
$MGO Global (MGOL.US)$ the only way for the gain post merger are shorts covering/close the position and boost the price up?
1
1
70177635
liked
$MGO Global (MGOL.US)$ I know the fucking Hmar wants 30:1. but I don’t know Stupid shareholders why agreed ?
3
5
70177635
voted
Brother Trump is preparing to assume office on January 20, 2025, several key policy initiatives are anticipated to be implemented immediately: ![]()
![]()
![]()
1. Energy ⚡️Policy Overhaul
• Maximizing Fossil Fuel Production: Trump plans to enhance U.S. oil and natural gas output by reducing regulations and bureaucratic hurdles. This includes lifting bans on offshore drilling and expediting energy infrastructure projects.
• Withdrawal from the Paris Agreement: Aiming...
1. Energy ⚡️Policy Overhaul
• Maximizing Fossil Fuel Production: Trump plans to enhance U.S. oil and natural gas output by reducing regulations and bureaucratic hurdles. This includes lifting bans on offshore drilling and expediting energy infrastructure projects.
• Withdrawal from the Paris Agreement: Aiming...
![Trump 🗓️ Jan 20, Big Changes are coming 🫣](https://sgsnsimg.moomoo.com/sns_client_feed/101793897/20250114/4781cce90a83af464c4bb79cad332d00.gif?area=101&is_public=true)
![Trump 🗓️ Jan 20, Big Changes are coming 🫣](https://sgsnsimg.moomoo.com/sns_client_feed/101793897/20250114/4e098b702c73692b0e0cd44392184aeb.jpg?area=101&is_public=true)
![Trump 🗓️ Jan 20, Big Changes are coming 🫣](https://sgsnsimg.moomoo.com/sns_client_feed/101793897/20250114/5d1f9b067e29c67ef928b307b2eac2bf.jpg?area=101&is_public=true)
+1
52
7
9
70177635
commented on
$HOOKIPA Pharma (HOOK.US)$
Poolbeg Pharma plc (“Poolbeg”) and HOOKIPA Pharma Inc. (“HOOKIPA”) Update on Potential Combination of Poolbeg and HOOKIPA
Poolbeg Pharma and HOOKIPA Pharma have announced important updates regarding their potential combination. Gilead Sciences, a significant HOOKIPA shareholder owning 19.4% (1,875,947 shares) of HOOKIPA's issued share capital, has indicated its intention to vote in line with HOOKIPA Board's recommendation for a formal offer and participate in the ...
Poolbeg Pharma plc (“Poolbeg”) and HOOKIPA Pharma Inc. (“HOOKIPA”) Update on Potential Combination of Poolbeg and HOOKIPA
Poolbeg Pharma and HOOKIPA Pharma have announced important updates regarding their potential combination. Gilead Sciences, a significant HOOKIPA shareholder owning 19.4% (1,875,947 shares) of HOOKIPA's issued share capital, has indicated its intention to vote in line with HOOKIPA Board's recommendation for a formal offer and participate in the ...
1
3
70177635
commented on
$XTI Aerospace (XTIA.US)$ Stock trading is not gambling, and it should be seen as taking a preemptive approach mindset and calculated risk.
Fortune favors the brave and I am not brave enough based on the historical data shown.
Fortune favors the brave and I am not brave enough based on the historical data shown.
![Good luck all! I'm out..](https://sgsnsimg.moomoo.com/sns_client_feed/102604939/20250107/1736231581879-random2219-102604939-android-org.jpeg/thumb?area=101&is_public=true)
2
70177635
voted
Hey mooers! Max here, wrapping up our exciting journey through the world of stock selection. ![]()
Can you believe how far we've come? Let's take a quick trip down memory lane:
1. We started by peeking into the portfolios of big institutions with the Institutional Tracker.
2. Then we hunted for passive income with the High Dividend Yield screener.
3. We got a bird's-eye view of the market with the Heat Map.
4. We explored entire industri...
Can you believe how far we've come? Let's take a quick trip down memory lane:
1. We started by peeking into the portfolios of big institutions with the Institutional Tracker.
2. Then we hunted for passive income with the High Dividend Yield screener.
3. We got a bird's-eye view of the market with the Heat Map.
4. We explored entire industri...
![Max Learns to Invest: Stock Selection Series - The Grand Finale](https://ussnsimg.moomoo.com/sns_client_feed/77777004/20241204/web-1733294571606-giphy.webp/thumb?area=999&is_public=true)
120
39
24